欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
2270	Sildenafil citrate, Micronised and non-micronised	MSN ORGANICS PRIVATE LIMITED Bibinagar Village IN	100012074;100018617	CEP 2013-219 - Rev 02	2026/03/13	Valid		Chemical	2026/03/13	Minor revision\|CEP granted\|13/03/2026; Minor revision\|CEP granted\|13/12/2021; Notification\|Accepted - CEP remains valid\|25/05/2020
3151	Cannabidiol	BSPG LABORATORIES LIMITED Sandwich GB	100033275;100051938	CEP 2024-370 - Rev 00	2026/03/13	Valid	13/03/2031	Chemical	2026/03/13	New application\|CEP granted\|13/03/2026
1335	Itraconazole, Unit IV (I)	NOSCH LABS PRIVATE LIMITED Hyderabad IN	100020550;100089573	CEP 2026-004 - Rev 00	2026/03/13	Valid	13/03/2031	Chemical	2026/03/13	New application\|CEP granted\|13/03/2026
272	Doxycycline hyclate	SHANDONG GUOBANG PHARMACEUTICAL CO., LTD. Weifang CN	100036834;100058198	CEP 2022-336 - Rev 01	2026/03/13	Valid	25/09/2029	Chemical	2026/03/13	Minor revision\|CEP granted\|13/03/2026; New application\|CEP granted\|25/09/2024
1373	Testosterone, Micronised	SYMBIOTEC PHARMALAB LIMITED Indore IN	100018972;100095999	CEP 2015-314 - Rev 02	2026/03/12	Valid		Chemical	2026/03/12	Notification\|CEP granted\|12/03/2026; Notification\|Accepted - CEP remains valid\|15/11/2023; Minor revision\|CEP granted\|30/06/2023; Renewal\|CEP granted\|15/06/2022; Minor revision\|Accepted - CEP remains valid\|18/10/2021; Monograph revision\|CEP granted\|27/07/2020
2331	Rabeprazole sodium hydrate	NOSCH LABS PRIVATE LIMITED Hyderabad IN	100020550;100089573	CEP 2018-158 - Rev 02	2026/03/12	Valid		Chemical	2026/03/12	Notification\|CEP granted\|12/03/2026; Minor revision\|Accepted - CEP remains valid\|18/06/2025; Renewal\|CEP granted\|30/10/2024
2219	Lansoprazole, Unit IV	NOSCH LABS PRIVATE LIMITED Hyderabad IN	100020550;100089573	CEP 2020-185 - Rev 02	2026/03/12	Valid		Chemical	2026/03/12	Notification\|CEP granted\|12/03/2026; Renewal\|CEP granted\|25/06/2025; New application\|CEP granted\|26/08/2020
2541	Quetiapine Fumarate	ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Dongyang CN	100022699;100078733	CEP 2025-013 - Rev 00	2026/03/12	Valid	12/03/2031	Chemical	2026/03/12	New application\|CEP granted\|12/03/2026
2531	Clopidogrel hydrogen sulfate, Form II, Process 3	SYNTHIMED LABS PRIVATE LIMITED Derabassi IN	100052287;100092080	CEP 2026-032 - Rev 00	2026/03/12	Valid	12/03/2031	Chemical	2026/03/12	New application\|CEP granted\|12/03/2026
1773	Cabergoline	LIFECARE LABORATORIES PRIVATE LIMITED Hyderabad IN	100049798;100086853	CEP 2023-093 - Rev 00	2026/03/12	Valid	12/03/2031	Chemical	2026/03/12	New application\|CEP granted\|12/03/2026
49	Paracetamol	IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana IN	100017919;100037377	CEP 2022-085 - Rev 01	2026/03/12	Valid	03/05/2028	Chemical	2026/03/12	Minor revision\|CEP granted\|12/03/2026; Minor revision\|Accepted - CEP remains valid\|22/08/2025; Minor revision\|Rejected\|01/07/2025; Major revision\|Accepted - CEP remains valid\|16/11/2023; New application\|CEP granted\|03/05/2023
2191	Atorvastatin calcium, TBAH Sulphate Route, Vijayasri Organics	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2024-464 - Rev 00	2026/03/11	Valid	11/03/2031	Chemical	2026/03/11	New application\|CEP granted\|11/03/2026
3095	Dabigatran etexilate mesilate, Form I, ACL	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2025-606 - Rev 00	2026/03/11	Valid	11/03/2031	Chemical	2026/03/11	New application\|CEP granted\|11/03/2026
1490	Amisulpride, Process 2	ICROM S.R.L. Concorezzo IT	100022464;100031145	CEP 2019-051 - Rev 05	2026/03/11	Valid		Chemical	2026/03/11	Minor revision\|CEP granted\|11/03/2026; Renewal\|CEP granted\|18/09/2024; Notification\|CEP granted\|21/11/2023; Minor revision\|CEP granted\|30/03/2021; Notification\|CEP granted\|27/11/2020; Notification\|Accepted - CEP remains valid\|24/08/2020
821	Estradiol hemihydrate, Process B, micronised	SHAANXI HANJIANG PHARMACEUTICAL GROUP CO., LTD. Hanzhong CN	100012369;100079669	CEP 2023-179 - Rev 01	2026/03/11	Valid	25/09/2029	Chemical	2026/03/11	Minor revision\|CEP granted\|11/03/2026; Major revision\|Accepted - CEP remains valid\|28/03/2025; New application\|CEP granted\|25/09/2024
714	Doxorubicin Hydrochloride	INTAS PHARMACEUTICALS LIMITED Ahmedabad IN	100011529;100023432	CEP 2012-367 - Rev 03	2026/03/11	Valid		Chemical	2026/03/11	Minor revision\|CEP granted\|11/03/2026; Notification\|Accepted - CEP remains valid\|13/10/2025; Minor revision\|CEP granted\|20/03/2024
780	Oxytocin	SHENZHEN JYMED TECHNOLOGY CO., LTD. Shenzhen CN	100042374;100070008	CEP 2015-376 - Rev 01	2026/03/11	Valid		Chemical	2026/03/11	Minor revision\|CEP granted\|11/03/2026; Monograph revision\|Accepted - CEP remains valid\|12/12/2023; Renewal\|CEP granted\|07/11/2022; Minor revision\|CEP granted\|28/05/2020
1700	Mycophenolate mofetil	EMCURE PHARMACEUTICALS LIMITED Pune IN	100011677;100099996	CEP 2019-089 - Rev 03	2026/03/11	Valid	24/08/2026	Chemical	2026/03/11	Notification\|CEP granted\|11/03/2026; Notification\|Rejected\|31/10/2024; Minor revision\|CEP granted\|21/04/2023; Minor revision\|CEP granted\|10/02/2022
931	Metformin Hydrochloride, Process-II	IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana IN	100017919;100037377	CEP 2025-564 - Rev 01	2026/03/11	Valid	05/03/2031	Chemical	2026/03/11	Administrative procedure\|CEP granted\|11/03/2026; New application\|CEP granted\|05/03/2026
2932	Rivaroxaban	BAJAJ HEALTHCARE LIMITED Thane IN	100021782;100061986	CEP 2023-085 - Rev 01	2026/03/11	Valid	30/04/2030	Chemical	2026/03/11	Minor revision\|CEP granted\|11/03/2026; New application\|CEP granted\|30/04/2025

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-